Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer, Inc. | PFE | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.04 | +0.11% | 36.2 | 36.36 | 35.87 | 35.89 | 36.16 | 15:29:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 48,813 | 10,848,993 | $ 36.1863 | $ 392.58M | 16.24M | 32.32 - 39.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:29:04 | 86 | $36.21 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 211.67B | 5.85B | $ 21.31B | 3.57 | 10.10 | 5.95B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.36 | 3.76% | 05/10/2018 | -330.49k | 77.40% |
Pfizer, Inc. News
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Jun 19, 2018 12:46 PM (3 hours ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Jun 19, 2018 12:46 PM (3 hours ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Jun 19, 2018 12:46 PM (3 hours ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Jun 19, 2018 12:45 PM (3 hours ago)
Pfizer Invites Public To View And Listen To Webcast Of July 31 Conference Call With Analysts Business Wire • Tue Jun 19, 2018 10:00 AM (6 hours ago)
Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infect... Business Wire • Tue Jun 12, 2018 7:00 AM (1 week ago)
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) • Fri Jun 08, 2018 1:57 PM (2 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 36.39 | 36.51 | 35.73 | 36.2493 | 13M | 27M | 18M | -0.19 | -0.52% |
| 1 Month | 35.8 | 36.8 | 35.32 | 36.1721 | 12M | 27M | 17M | 0.4 | 1.12% |
| 3 Months | 35.18 | 37.265 | 34.37 | 35.8849 | 11M | 43M | 18M | 1.02 | 2.90% |
| 6 Months | 37.2 | 39.43 | 33.2 | 36.0811 | 7M | 49M | 19M | -1 | -2.69% |
| 1 Year | 33.21 | 39.43 | 32.32 | 35.4717 | 6M | 49M | 17M | 2.99 | 9.00% |
| 3 Years | 34.41 | 39.43 | 28.25 | 33.3656 | 6M | 280M | 23M | 1.79 | 5.20% |
| 5 Years | 28.08 | 39.43 | 27.33 | 32.2599 | 1k | 280M | 24M | 8.12 | 28.92% |
Pfizer, Inc. Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
